Making your mind up can be hard, especially when you don’t have all of the facts.
Our booster menu has never been so diverse and it is normal to feel a little lost in all of it. Both Moderna and Pfizer have bivalent vaccines targeting the original strain and either the Omicron sub-variant BA.1 or BA.4/5.
But don’t worry too much, like our friend Amanda confides in her diary, all four bivalent vaccines are great and are predicted to provide better protection against the current variants than the original formula. If you got any of the original boosters you should not worry either as they too will protect you against severe outcomes and hospitalization from COVID-19.
The best booster you can get this fall is the one that is available to you.
View our original Tweet!
Our booster menu has never been so diverse and it is normal to feel a little lost in all of it.
We have managed to retrieve some very private and exclusive footage of our Amanda writing in her diary about the four authorized bivalent vaccines. #ScienceUpFirst
[1/3] pic.twitter.com/17xFVqJuS3
— ScienceUpFirst | LaScienced’Abord (@ScienceUpFirst) November 16, 2022
View our original Instagram Post!
View this post on Instagram
- How do bivalent boosters compare? / Comparons les vaccins bivalents
- 5 things to know about bivalent vaccines / 5 choses a savoir sur les vaccins bivalents
- Summary of National Advisory Committee on Immunization (NACI) Statement of November 3, 2022 | Résumé de la déclaration du CCNI du 3 novembre 2022
- References
- Moderna Spikevax COVID-19 vaccine | Vaccin Spikevax de Moderna contre la COVID-19
- Pfizer-BioNTech Comirnaty COVID-19 vaccine | Vaccin Comirnaty de Pfizer-BioNTech contre la COVID-19
- Product monograph including patient medication information – Comirnaty original & Omicron BA.4/BA.5 | Monographie avec renseignements destinés aux patients – Comirnaty original & omicron BA.4/BA.5
- Health Canada authorizes COVID-19 vaccine booster targeting the Omicron BA.4/BA.5 subvariants | Santé Canada homologue un vaccin de rappel contre la COVID-19 ciblant les sous-variants BA.4 et BA.5 d’Omicron
- Regulatory Decision Summary – Spikevax Bivalent (Original/Omicron BA.4/5) | Sommaire de décision réglementaire – Spikevax Bivalent (Original/Omicron BA.4/5)
- NACI updated guidance on COVID-19 vaccine booster doses in Canada | Directives mises à jour du CCNI sur les doses de rappel du vaccin contre la COVID-19 au Canada
- Summary of National Advisory Committee on Immunization (NACI) Statement of October 7, 2022 | Résumé de la déclaration du CCNI du 7 octobre 2022
